menu
    • menu

    Company profile for Oncternal Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer progression.The pipeline includes cirmtuzumab, a monoclonal antibody in Phase 1/2 development that inhibits the ROR1 receptor in various hematologic cancers; TK-216, a small-mole...
    Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer progression.The pipeline includes cirmtuzumab, a monoclonal antibody in Phase 1/2 development that inhibits the ROR1 receptor in various hematologic cancers; TK-216, a small-molecule in Phase 1 development that inhibits ETS-family oncoproteins, as a treatment for Ewing sarcoma, a rare pediatric cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Oncternal TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    12230 El Camino Real, Suite 300 San Diego, CA 92130
    Telephone
    Telephone
    (858) 434 1113
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.oncternal.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/oncternal-therapeutics?trk=companies_directory
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/oncternal

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oncternal Therapeutics Sells Programs and Winds Down Operations
    Oncternal Therapeutics Sells Programs and Winds Down Operations

    01 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/01/3108259/0/en/Oncternal-Therapeutics-Announces-the-Sale-of-Select-Development-Programs-and-the-Wind-Down-of-its-Operations.html

    GLOBENEWSWIRE
    01 Jul 2025
    Share Share
    Oncternal Therapeutics to Delist from Nasdaq and Deregister
    Oncternal Therapeutics to Delist from Nasdaq and Deregister

    07 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/07/3039235/0/en/Oncternal-Therapeutics-Announces-Intent-to-Voluntarily-Delist-from-Nasdaq-and-Deregister-with-the-SEC.html

    GLOBENEWSWIRE
    07 Mar 2025
    Share Share
    Oncternal Announces Updated Data For ONCT-534 In Prostate Cancer
    Oncternal Announces Updated Data For ONCT-534 In Prostate Cancer

    22 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/22/2967000/0/en/Oncternal-Therapeutics-Announces-Updated-Safety-and-Efficacy-Data-for-Phase-1-2-Study-of-ONCT-534-for-the-Treatment-of-R-R-Metastatic-Castration-Resistant-Prostate-Cancer.html

    GLOBENEWSWIRE
    22 Oct 2024
    Share Share
    Oncternal Therapeutics Terminates Clinical Studies, Explores Alternatives
    Oncternal Therapeutics Terminates Clinical Studies, Explores Alternatives

    12 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/12/2945259/0/en/Oncternal-Therapeutics-Announces-Termination-of-its-Clinical-Studies-and-Exploration-of-Strategic-Alternatives.html

    GLOBENEWSWIRE
    12 Sep 2024
    Share Share
    Oncternal Therapeutics Reports Q2 2024 Results And Business Update
    Oncternal Therapeutics Reports Q2 2024 Results And Business Update

    08 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/08/2927288/0/en/Oncternal-Therapeutics-Provides-Business-Update-and-Announces-Second-Quarter-2024-Financial-Results.html

    GLOBENEWSWIRE
    08 Aug 2024
    Share Share
    Oncternal Therapeutics To Report Q2 2024 Results And Business Update
    Oncternal Therapeutics To Report Q2 2024 Results And Business Update

    01 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/01/2923180/0/en/Oncternal-Therapeutics-to-Provide-Business-Update-and-Report-Second-Quarter-2024-Financial-Results.html

    GLOBENEWSWIRE
    01 Aug 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search